November 27, 2015 Newsletter
Carolann is out of the office, I will be writing the newsletter on her behalf.
PHOTOS OF THE DAY
Sinclair Oil’s green Dino float proceeds high above spectators along 6th Ave during the 89th Macy’s Thanksgiving Day Parade in the Manhattan borough of New York Thursday. Carlo Allegri/Reuters
The buildings around the Grand Place are illuminated during the opening of the Christmas Market in Brussels, Belgium, Friday. Brussels lowered its terror alert from four to three. Michael Probst/AP
Market Closes for November 27th, 2015
|Bonds||% Yield||Previous % Yield|
10 Year Bond
10 Year Bond
30 Year Bond
|WTI Crude Future||41.71||41.79
By Eric Lam
(Bloomberg) — Canadian stocks fell, capping a weekly loss, as raw-materials producers retreated with gold prices tumbling to a five-year low amid increasing bets the Federal Reserve will raise interest rates next month.
The Canadian equity market, one of the worst-performing in the world this year amid a slump in commodities prices, is poised to beat its U.S. peers for the first time since 2010 next year as investors have gotten overly pessimistic, according to BMO Capital Markets Chief Investment Strategist Brian Belski.
“Canada is down, but not out,” Belski said in a 2016 market outlook report to clients Nov. 25. “The recovery we expected in the fourth quarter has only been delayed and is one of the main reasons we believe Canada will be a surprise outperformer in 2016. Any positive news stemming from emerging markets, Europe and commodity prices will likely be a strong positive tailwind for Canadian stocks.”
The Standard & Poor’s/TSX Composite Index fell 56.95 points, or 0.4 percent, to 13,368.24 at 4 p.m. in Toronto. It has dropped 8.6 percent this year, trailed only by Singapore and Greece among developed markets.
Belski forecasts the S&P/TSX to close 2016 at 15,300, a 14 percent increase from current levels. Most global managers are now “grossly underweight” Canadian equities, he said.
“The ‘Eeyore’ market continues, as most Canadian-centric investors continue to focus on the doom-and-gloom trade while dictating their investment conclusions with fear and emotion,” Belski said.
Energy and raw-materials producers, along with health-care stocks, have fallen at least 22 percent this year to lead declines in the S&P/TSX. A combination of slowing economic growth in China and a rally in the U.S. dollar due to impending interest-rate increases from the Fed as soon as December have crimped commodities prices.
Barrick Gold Corp. and Goldcorp Inc. dropped at least 2.6 percent as raw-materials producers lost 2.1 percent as a group, the most in the benchmark equity gauge. Gold futures fell 1.3 percent to settle at $1,056.20 an ounce in New York. Gold posted its sixth straight week of losses, the longest such run in two years.
Canadian Oil Sands Ltd. retreated 5.6 percent for the worst loss in almost two months. Suncor Energy Inc. yesterday said it may scrap its $4.5 billion hostile bid for the company if Alberta regulators endorse a poison pill that would give the target company more time to find other bidders. Oil producers tumbled 1.3 percent as crude futures fell 3.1 percent in New York, paring a weekly advance.
By Anna-Louise Jackson
(Bloomberg) — The year’s strongest week for U.S. equities was followed by one of its quietest, with energy stocks underpinning microscopic gains in a holiday-shortened week.
Stocks moved the smallest amount since July as the Thanksgiving holiday damped trading following the previous week’s 3.3 percent surge in the Standard & Poor’s 500 Index. Mixed economic results and geopolitical unrest did little to sway equities ahead of next week’s jobs report and a Federal Reserve meeting scheduled to conclude on Dec. 16.
The S&P 500 rose 0.04 percent in the 3 1/2 days to 2,090.11, its eighth gain in nine weeks. The gauge closed 1.9 percent below its May peak and, with one day left in November, is up 0.5 percent for the month after rallying 8.3 percent in October. The Russell 2000 Index surged 2.3 percent for the week to close at its highest level since Aug. 19.
Volume was light as investors honed their focus on the future of monetary policy in the U.S., said David Donabedian, chief investment officer of Atlantic Trust Private Wealth Management, which oversees $27 billion. “The market continues to come to peace with the idea that the Fed will do its first increase in mid-December.”
Compared with where they were leading up to the last Fed meeting in October, equities are in a much improved state. At the start of that month, the S&P 500 was still down 8.6 percent from its August high, while the Chicago Board Options Exchange Volatility Index was at 22.55. Three weeks ahead of the forthcoming meeting, shares in the benchmark gauge are back in the range they were trading weeks before the correction started and the VIX has retreated back to 15.12, just above its pre- selloff average of 14.9.
Still, it’s not like investors have made up their minds about the future. The S&P 500 has alternated gains and losses over the last nine straight sessions, the longest such streak since 2013.
Companies with a heavier domestic revenue stream are the likeliest to do well amid economic reports that show positive U.S. growth — or at the very least, “numbers that aren’t near as bad,” said Tom Stringfellow, president and chief investment officer of San Antonio-based Frost Investment Advisors LLC, which manages about $11 billion. “What’s really getting a bid right now are those companies that are less impacted by dollar strength overseas.”
Economic reports showed mixed results. Orders for U.S. business equipment climbed more than forecast in October, indicating steady domestic demand is encouraging corporate investment even as global sales waver. Meanwhile, consumers are benefiting from accelerating income gains, though that didn’t translate to higher household spending or confidence measures.
The week’s economic data didn’t change the course of a potential rate hike and “the market’s waiting for what the Fed’s actually going to do,” said Bob Baur, chief global economist at Principal Global Investors in Des Moines, Iowa. The firm oversees $333 billion. It’s also taking a breather because October’s “huge rebound might’ve been a little too much, too fast,” he said.
The probability of a boost to interest rates in next month’s meeting is 72 percent, according to fed fund futures. Amid more certainty about the timing, “the only thing that might change it is if we have a hugely discouraging jobs report,” Baur said. And even that doesn’t seem very likely given the decline in initial unemployment claims.
Similarly, the market was unfazed by renewed concerns about geopolitical tensions after a Russian warplane was downed by Turkish forces. Meanwhile, Pfizer Inc.’s $160 billion megadeal with Allergan Plc was met by a cool reception. Allergan rose 2.3 percent on the week while Pfizer increased 1.9 percent.
Higher oil prices helped to spur a 1.3 percent gain for energy stocks, capping a second consecutive week of gains. Meanwhile, consumer-staples stocks rose each day of trading to close at the highest level in more than three weeks. Utility stocks, the week’s biggest laggard, fell 1.6 percent.
A volatility measure fell for a second consecutive week. The Chicago Board Options Exchange Volatility Index has tumbled more than 60 percent after spiking to the highest in almost four years during the S&P 500’s summer swoon. Investors may need to brace for higher volatility ahead of the Fed’s meeting.
“We still will see volatility, particularly because there’s a lot of lead-up to the Fed meeting,” said Tom Anderson, who helps oversee about $8 billion as chief investment officer at Boston Private Wealth. “We’ll likely have choppiness over the coming weeks.”
Have a wonderful weekend everyone.
Carolann Steinhoff, B.Sc., CFP®, CIM, CIWM
Portfolio Manager &
Queensbury Securities Inc.,
St. Andrew’s Square,
Suite 340A, 730 View St.,
Victoria, B.C. V8W 3Y7